Profile
Daniel Brodén worked as a Financial Manager at GU Ventures AB, Chief Financial Officer at Toleranzia AB, Chief Financial Officer at Cereno Scientific AB, and Auditor at PricewaterhouseCoopers AB. He also worked as an Auditor at Frejs Revisorer AB from 2012 to 2015.
Brodén received his undergraduate degree from the University of Uppsala in 2010 and his graduate degree from the University of Gothenburg.
Former positions of Daniel Brodén
| Companies | Position | End |
|---|---|---|
Frejs Revisorer AB
Frejs Revisorer AB Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax preparation and accounting services | Corporate Officer/Principal | 01/09/2015 |
PricewaterhouseCoopers AB
PricewaterhouseCoopers AB Miscellaneous Commercial ServicesCommercial Services Provides auditing services | Corporate Officer/Principal | - |
GU Ventures AB
GU Ventures AB Investment ManagersFinance GU Ventures invests in companies located in Sweden. The firm targets companies operating in the fields of life science and technology sectors. It provides financing for early stage capital requirements and also makes co-investments. | Corporate Officer/Principal | - |
| TOLERANZIA AB | Director of Finance/CFO | - |
| CERENO SCIENTIFIC AB | Director of Finance/CFO | - |
Training of Daniel Brodén
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Gothenburg
University of Gothenburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GU Ventures AB
GU Ventures AB Investment ManagersFinance GU Ventures invests in companies located in Sweden. The firm targets companies operating in the fields of life science and technology sectors. It provides financing for early stage capital requirements and also makes co-investments. | Finance |
Toleranzia AB
Toleranzia AB BiotechnologyHealth Technology Operates as a biotechnology company that develops drugs for the treatment of autoimmune orphan diseases | Health Technology |
PricewaterhouseCoopers AB
PricewaterhouseCoopers AB Miscellaneous Commercial ServicesCommercial Services Provides auditing services | Commercial Services |
Cereno Scientific AB
Cereno Scientific AB Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Frejs Revisorer AB
Frejs Revisorer AB Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax preparation and accounting services | Commercial Services |
- Stock Market
- Insiders
- Daniel Brodén
















